Pantoprazole Induces Apoptosis of Leukemic Cells by Inhibiting Expression of P-Glycoprotein/Multidrug Resistance-Associated Protein-1 Through PI3K/AKT/mTOR Signaling
出版年份 2017 全文链接
标题
Pantoprazole Induces Apoptosis of Leukemic Cells by Inhibiting Expression of P-Glycoprotein/Multidrug Resistance-Associated Protein-1 Through PI3K/AKT/mTOR Signaling
作者
关键词
Pantoprazole, Proton pump inhibitor, Leukemia, PI3K/AKT/mTOR signaling, P-glycoprotein, Multidrug resistance-associated protein-1
出版物
Indian Journal of Hematology and Blood Transfusion
Volume 33, Issue 4, Pages 500-508
出版商
Springer Nature
发表日期
2017-03-30
DOI
10.1007/s12288-017-0808-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
- (2016) Timon Vandamme et al. BRITISH JOURNAL OF CANCER
- Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase
- (2016) Xiaoyu Zeng et al. Oncotarget
- Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
- (2015) Stefan Wolking et al. CLINICAL PHARMACOKINETICS
- MRP1 and its role in anticancer drug resistance
- (2015) Jamie F. Lu et al. DRUG METABOLISM REVIEWS
- Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma
- (2015) Zhi-Chao Wang et al. TUMOR BIOLOGY
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
- (2015) James Andrew McCubrey et al. Oncotarget
- in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells
- (2014) Melva Louisa et al. Asian Pacific Journal of Cancer Prevention
- PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
- (2014) Fang-Fang Huang et al. PLoS One
- Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1
- (2014) Hongye Ma et al. PLoS One
- Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia
- (2013) Kerstin Kampa-Schittenhelm et al. Molecular Cancer
- Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho-LRP6 expression in Wnt/β-catenin signaling
- (2013) WEIDONG SHEN et al. ONCOLOGY REPORTS
- Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia
- (2013) Susanne Badura et al. PLoS One
- Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes
- (2012) Huizhe Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo
- (2012) Min Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
- (2011) A M Martelli et al. LEUKEMIA
- Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia
- (2009) Jehan A El-Sharnouby et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now